Cargando…

Is adjuvant chemotherapy necessary in older patients with breast cancer?

BACKGROUND: Due to the lack of clinical trials on the efficacy of chemotherapy in older patients, an optimal treatment strategy has not been developed. We investigated whether adjuvant chemotherapy could improve the survival of older patients with breast cancer in Japan. METHODS: We retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morita, Midori, Shimomura, Akihiko, Tokuda, Emi, Horimoto, Yoshiya, Kawamura, Yukino, Ishizuka, Yumiko, Sekine, Katsutoshi, Obayashi, Sayaka, Kojima, Yuki, Uemura, Yukari, Higuchi, Toru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021076/ https://www.ncbi.nlm.nih.gov/pubmed/35032302 http://dx.doi.org/10.1007/s12282-021-01329-7

Ejemplares similares

Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
por: Horimoto, Yoshiya, et al.
Publicado: (2022)

Acute myocarditis during adjuvant therapies for breast cancer: a case report
por: Ushiyama, Yumiko, et al.
Publicado: (2023)

Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer
por: Horimoto, Yoshiya, et al.
Publicado: (2014)

Clinicopathological features of breast cancer without mammographic findings suggesting malignancy
por: Nakamura, Mei, et al.
Publicado: (2020)

Microsatellite-Stable Radiation-Induced Angiosarcoma after Breast-Conserving Surgery: A Case Report
por: Ishizuka, Yumiko, et al.
Publicado: (2020)

Drug-induced aortitis of the subclavian artery caused by pegfilgrastim: a case report
por: Jimbo, Hikari, et al.
Publicado: (2021)

Clinicopathological Examination of Metaplastic Spindle Cell Carcinoma of the Breast: Case Series
por: Ishizuka, Yumiko, et al.
Publicado: (2021)

Clinicopathological features, genetic alterations, and BRCA1 promoter methylation in Japanese male patients with breast cancer
por: Shimomura, Akihiko, et al.
Publicado: (2022)

Clinicopathological Features Related to the Efficacy of CDK4/6 Inhibitor-Based Treatments in Metastatic Breast Cancer
por: Shikanai, Ayana, et al.
Publicado: (2022)

Extent of weight reduction necessary for minimization of diabetes risk in Japanese men with visceral fat accumulation and glycated hemoglobin of 5.6–6.4%
por: Iwahashi, Hiromi, et al.
Publicado: (2015)

Overcoming the Adverse Effects of Everolimus to Achieve Maximum Efficacy in the Treatment of Inoperable Breast Cancer: A Review of 11 Cases at Our Hospital
por: Yoshida-Ichikawa, Yuko, et al.
Publicado: (2018)

Primary breast non-Hodgkin’s lymphoma in a 14-year-old girl: a case report
por: Ishizuka, Yumiko, et al.
Publicado: (2020)

IgG4-related mastitis characterized by skin thickening of the breast: a case report
por: Itakura, Moe, et al.
Publicado: (2023)

Is adjuvant chemotherapy necessary for early gastric cancer?
por: Mei, Yu, et al.
Publicado: (2022)

A Gastric Metastatic Lesion That Resembled Early-Stage Gastric Cancer on Endoscopy during Treatment for Recurrent Breast Cancer: A Case Report
por: Watanabe, Yukino, et al.
Publicado: (2021)

A Case of Recurrent Ovarian Cancer and Therapy-Related Acute Myeloid Leukemia Treated with Azacitidine
por: Ando, Kenju, et al.
Publicado: (2021)

Breast Cancer Treatment in a Patient with Decubitus Ulcer Infection Secondary to Spina Bifida: Surgical Resection versus Neoadjuvant Chemotherapy
por: Sato, Fumiya, et al.
Publicado: (2021)

Response to lenvatinib and pembrolizumab combination therapy in pembrolizumab-pretreated relapsed endometrial cancer
por: Mimura, Kaito, et al.
Publicado: (2022)

Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study
por: Horimoto, Yoshiya, et al.
Publicado: (2018)

Clinicopathological and molecular pathological characteristics in tamoxifen‑related endometrial cancer
por: Saeki, Harumi, et al.
Publicado: (2023)

Is adjuvant chemotherapy necessary for patients with microinvasive breast cancer after surgery?
por: Niu, Hai-Fei, et al.
Publicado: (2016)

Is adjuvant chemotherapy necessary in pT1N1 gastric cancer?
por: Shin, Hyun Beak, et al.
Publicado: (2017)

Tamoxifen-resistant breast cancer cells exhibit reactivity with Wisteria floribunda agglutinin
por: Hlaing, May Thinzar, et al.
Publicado: (2022)

Granular Cell Tumor of the Breast Coexisting with Ductal Carcinoma in situ: Case Report
por: Ueki, Yuko, et al.
Publicado: (2021)

Intrinsic subtype distribution should vary according to institutions
por: Horimoto, Yoshiya, et al.
Publicado: (2020)

Microsatellite instability and mismatch repair protein expressions in lymphocyte‐predominant breast cancer
por: Horimoto, Yoshiya, et al.
Publicado: (2020)

Intracranial venous reflux without the central venous occlusive disease in a patient receiving hemodialysis through brachio-brachial arteriovenous fistula: A case report
por: Ito, Sayaka, et al.
Publicado: (2022)

Cardiotoxicity of adjuvant chemotherapy with trastuzumab: a Japanese claim-based data analysis
por: Ohtsu, Hiroshi, et al.
Publicado: (2022)

Pathology of healing: what else might we look at?
por: Horimoto, Yoshiya, et al.
Publicado: (2016)

High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs
por: Onagi, Hiroko, et al.
Publicado: (2022)

Possible correlation of apical localization of MUC1 glycoprotein with luminal A-like status of breast cancer
por: Semba, Ryoko, et al.
Publicado: (2023)

Dendritic Cell-Based Adjuvant Vaccination Targeting Wilms’ Tumor 1 in Patients with Advanced Colorectal Cancer
por: Shimodaira, Shigetaka, et al.
Publicado: (2015)

Eight years post-Fukushima: is forest decontamination still necessary?
por: Taira, Yasuyuki, et al.
Publicado: (2019)

A high ratio of IC31(®) adjuvant to antigen is necessary for H4 TB vaccine immunomodulation
por: Aboutorabian, Sepideh, et al.
Publicado: (2015)

Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases
por: Horimoto, Y, et al.
Publicado: (2015)

Severe cytopenia during adjuvant chemotherapy for early breast cancer in a patient with idiopathic CD4+ lymphocytopenia
por: Mimura, Kaito, et al.
Publicado: (2023)

Comparison of an AC‐taxane versus AC‐free regimen and paclitaxel versus docetaxel in patients with lymph node‐positive breast cancer: Final results of the National Surgical Adjuvant Study of Breast Cancer 02 trial, a randomized comparative phase 3 study
por: Watanabe, Toru, et al.
Publicado: (2017)

Is a proton-pump inhibitor necessary after endoscopic submucosal dissection for superficial esophageal neoplasms? A propensity score analysis
por: Kanaoka, Hideaki, et al.
Publicado: (2020)

Factors necessary for independent walking in patients with thalamic hemorrhage
por: Hiraoka, Shigenori, et al.
Publicado: (2017)

Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients
por: Obayashi, Sayaka, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9u9963i2hr98eulftvqiohno7i